10.07.2015 Views

220-Dictionary of Pharmaceutical Medicine, 2nd Edition-Gerhard Nahler Annette Mollet-3211898352-S

220-Dictionary of Pharmaceutical Medicine, 2nd Edition-Gerhard Nahler Annette Mollet-3211898352-S

220-Dictionary of Pharmaceutical Medicine, 2nd Edition-Gerhard Nahler Annette Mollet-3211898352-S

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

11exposed to the risk factor (more correct: a proportion, not a rate; refersusually to infectious diseases); → see also incidence, outcomemeasurement, prevalence rate, secondary attack rate.attributable risk → see risk.audit Inspection <strong>of</strong> facilities, documentation and procedures <strong>of</strong> clinicalinvestigator, sponsor, contract research organisation,ethics committee etc; audits are made to ensure that either theinternal system or a trial is performed in accordance with goodclinical practice (GCP)/GXP and national law, including ethicalconsiderations as well as that raw data and associated recordshave been accurately reported, and to establish whether practiceswere employed in the development <strong>of</strong> data that would impair theirvalidity; audits are part <strong>of</strong> a quality assurance system; audits orinspections usually start with an opening meeting and end with aclosing meeting (→ see exit interview); types <strong>of</strong> a.: <strong>of</strong>ficial externala. = inspection by a supervisory authority, un<strong>of</strong>ficial external a. =visit by a service company contract service organisation, CROon request by the sponsor, un<strong>of</strong>ficial internal a. = carried out byan internal structure (e.g. quality assurance department, parentcompany) EC (III): “An internal a. independent <strong>of</strong> those participatingin the trial should be conducted by or on behalf <strong>of</strong> the sponsorto assure the integrity <strong>of</strong> the quality control system”; “the sponsoris responsible for conducting an internal a. <strong>of</strong> the trial” and forassuring “the investigators’ acceptance <strong>of</strong> verification procedures,audit, and inspection”; a. are performed either as “during-study” a.or as “post-study” a.; usually the written final “Evaluation Report”reveals only findings e.g. deficiencies; an a. is not a scientific evaluation<strong>of</strong> the data <strong>of</strong> a study; a trial audit is a comparison <strong>of</strong> raw dataand associated records with the interim or final report; a regulatorya. is the verification <strong>of</strong> the credibility <strong>of</strong> data and the evaluation<strong>of</strong> the design, planning, conduct, monitoring and reporting <strong>of</strong> aclinical trial against regulatory requirements; further types <strong>of</strong>audits are: management a. = evaluates the efficiency and economy<strong>of</strong> a given operation in terms <strong>of</strong> accounting, purchasing, producing,personnel and research; program a. = evaluates effectivenessby a higher level <strong>of</strong> authority; a. can also be performed on productionplants and laboratory facilities to ensure adherence to goodmanufacturing practice (GMP) or good laboratory practice(GLP) respectively; → see also acceptable quality level, confidentiality,data quality, establishment inspection report,exit interview, iso/dis 10011-2, medical a.audit certificate Document which certifies that an audit has takenplace; has to be stored together with the audit report in the trialmaster file; → see also data trail.aud

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!